Dyslipidemia, characterized by abnormal levels of total cholesterol (TC), non–high-density lipoprotein cholesterol (non-HDL-C), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglycerides (TG), is a well-established risk factor for atherosclerotic cardiovascular disease.
1-3 Substantial evidence has shown that lipid disorders are associated with subclinical atherosclerosis in youth,
4-6 suggesting that the process of atherosclerosis originates early in life. Childhood lipid disorders have been shown to persist or track into adulthood
7,8 and thus contribute to the increased risk of cardiovascular disease. Current pediatric guidelines for cardiovascular health and risk reduction by the National Heart, Lung, and Blood Institute recommend universal lipid screening in childhood.
9 Therefore, identification and intervention of dyslipidemia in early life may prevent and reduce future cardiovascular events.